A controversy is swirling at a Texas university. The trigger? A flowchart. On Dec. 1, the new chancellor of the Texas Tech University system sent professors a diagram laying out a chain of approval ...

Forbes contributors publish independent expert analyses and insights. I write about transforming businesses through technology & innovation. Tariffs are shaking up American manufacturing. Hurting some ...

“Our customers, in partnership with federal and state agencies, are reshoring drug manufacturing in the U.S., the world’s largest pharmaceutical market. Local API production is vital for supply chain ...

After months of merchant frustration over securing the required API key for website-reported local inventory feeds via Google Tag Manager, Google has now confirmed a straightforward process: Why we ...

Eli Lilly has revealed the location of the second of its four large-scale manufacturing facilities that it plans to build in the U.S., selecting Houston as home to a $6.5 billion plant that will ...

While the United Kingdom feted President Trump in his second state visit, GSK said Wednesday it will spend $30 billion over the next five years to build new manufacturing and research facilities ...

India’s Hikal Limited has been hit with an FDA warning letter chiding the drug ingredients manufacturer for failing to uncover the cause of dozens of complaints of metal contamination in its products.

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

Joe Guiles, PhD, is Head of Chemical Development at Agilent Technologies. With extensive pharma and biotech experience, he leads development for clinical and commercial stage therapeutic APIs. Over ...